john eng glp 1 Who should win a Nobel for the science of the Ozempic revolution? GLP-1-based therapy for obesity -
Description
[DOI] [PubMed] [Google Scholar] 53.Mansour M.R., Hannawa O.M., Yaldo M.M., Nageeb E.M., Chaiyasate K
Glucagon-like peptide 2
However, neuronal ROS production was reduced, while astrocytic ROS levels increased, suggesting possible differential effects on mitochondrial function [85]
More importantly, GLP1R negatively regulates autophagy activity through the ERK1/2-HDAC6 signalling pathway
Without clinical data, effectiveness remains largely unproven outside of anecdotal data
